Author

Greta Rogani

Observed name: Rogani, Greta

Institutions: Utrecht University, University Medical Center Utrecht, Wilhelmina Children's Hospital

Observed institutions: University of Milan, Utrecht University, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University Medical Center Utrecht, Wilhelmina Children's Hospital

ORCID: 0000-0002-3922-7224

Observed ORCID: 0000-0002-3922-7224

OpenAlex ID: A5076598103

Current treatment in macrophage activation syndrome worldwide: a systematic literature review to inform the METAPHOR project

2024 · Francesco Baldo, Remco G A Erkens, et al. · Lara D. Veeken · 44

Corticosteroid Treatment in Sydenham Chorea: A 27-Year Tertiary Referral Center Experience

2023 · Alberto Maria Cappellari, Greta Rogani, et al. · Children · 5

Impact of Interleukin‐1 Blockade on the Development of Macrophage Activation Syndrome in Still Disease: Incidence and Diagnostic Validity of the EULAR / ACR / PRINTO 2016 MAS Classification Criteria

2025 · Remco G. A. Erkens, Greta Rogani, et al. · Arthritis & Rheumatology · 3

Infection-Triggered Hyperinflammatory Syndromes in Children

2022 · Martina Rossano, Greta Rogani, et al. · Children · 3

Can early-onset acquired demyelinating syndrome (ADS) hide pediatric Behcet's disease? A case report

2023 · Mattia Pozzato, Robertino Dilena, et al. · Frontiers in Pediatrics · 2

Pathogenic and genetic landscape of Still’s disease across ages, with new insights into age-related IL-18 patterns

2026 · Greta Rogani, Haeja Kessler, et al. · Arthritis Research & Therapy · 1

Treatment approaches to macrophage activation syndrome in real life and priorities for future research: results from the international METAPHOR project

2026 · Francesco Baldo, Greta Rogani, et al. · Arthritis & Rheumatology

Persistent Interleukin‐18 Fuels Expansion of CD38 + HLA ‐ DR + CD8 + T Cells in Still Disease and Macrophage Activation Syndrome

2026 · Greta Rogani, Remco G. A. Erkens, et al. · Arthritis & Rheumatology

Complement Activation Linked to Type II Interferon Signaling in Still Disease

2026 · Freya M. C. H. Huijsmans, Tabea Thalheim, et al. · Arthritis & Rheumatology

LDL receptor–mediated lipoprotein uptake fuels human CD4+ T cell polarization toward a c-MAF/IL-10– and FOXP3-driven phenotype

2026 · Angela Markovska, Niels S. van Heusden, et al. · JCI Insight

Current treatment in macrophage activation syndrome worldwide

2026 · Baldo, Francesco, Erkens, Remco G. A., et al. · DiRROS repository (University of Maribor)

Works count: 12

Citation count: 58

H-index: 3

I10-index: 1